I too am frustrated with the sp and of late the company. I have sent them many emails seeking an update. Particularly in regards to the companies response to the asx query in March this year. A number of the companies answers related to obtaining CDFA approval before the medtell contract can start and more broadly the sale of prizmas. Further more as stated In the last 4c is not anticipating to spend any funds on production this quarter. So overall a lot of issues that need addressing and hence the downward slow of the sp. the market was clearly expecting the factory to commence productIon and mous turned Into contracts. However an update any day could change all this.
GMV Price at posting:
27.0¢ Sentiment: Buy Disclosure: Held